EUVIMEDEUVIMED entdecken
Crossref

Precision photodamage of RNA and mitochondria for cancer therapy with upconversion nanoparticles

Shuwen Cheng, Menghang Chen, Yihan Wu, Jinliang Liu, Xiaoqin Zhong, Yong Zhang, Qingqing Dou

Microchimica Acta · 2025

DOI: 10.1007/s00604-025-07332-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Shuwen Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Mitochondria, Photochemotherapy, Nanoparticles, Photosensitizing Agents. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) is an emerging approach for cancer treatment that circumvents the discomfort associated with surgical interventions; however, its therapeutic effectiveness remains constrained. In this study, an innovative nanoplatform is introduced that is designed to enhance the efficacy of PDT by specifically targeting RNA and mitochondria, along with providing real-time in vivo imaging capabilities. The nanoplatform is constructed from a multifunctional nanocomposite, UCNP@PEI-RB-furan (referred to as UPRf), integrates several critical components: upconversion nanoparticles (UCNPs) to facilitate light penetration into deep tissue, Rose Bengal (RB) to generate reactive oxygen species (ROS) including singlet oxygen (1O2) for cancer cell destruction, a furan moiety for RNA crosslinking in the presence of 1O2, and polyethylenimine (PEI) for electrostatically binding to mitochondria. This design offers multiple benefits, including the absence of phototoxicity in sunlight since PDT is activated by near-infrared (NIR) light, significant cell destruction by targeting the energy-producing organelles-mitochondria, and disruption of cellular function through damage to cytoplasmic RNA. The findings show that the nanoplatform achieved remarkable cancer regression both in vitro and in vivo, outperforming non-targeting alternatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaPhotochemotherapyNanoparticlesPhotosensitizing AgentsRNAHumansAnimalsMiceRose BengalSinglet OxygenPolyethyleneimineCell Line, TumorReactive Oxygen SpeciesNeoplasms

Stichwörter der Autor:innen

Mitochondria targetingPhotodynamic therapyRNA targetingUpconversion nanoparticles

Substanzen

Photosensitizing AgentsRNARose BengalSinglet OxygenPolyethyleneimineReactive Oxygen Species

Autor:innen und Institutionen

  • School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China.
  • Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, 999077, SAR, China. xiaoqin_zhong@shu.edu.cn.
  • Periodicals Agency of Shanghai University, Shanghai University, Shanghai, 200444, China. yozhang@cityu.edu.hk.
  • School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China. douq@shu.edu.cn.

Zitieren

APA

Cheng, S., Chen, M., Wu, Y., Liu, J., Zhong, X., Zhang, Y., & Dou, Q. (2025). Precision photodamage of RNA and mitochondria for cancer therapy with upconversion nanoparticles. Microchimica Acta. https://doi.org/10.1007/s00604-025-07332-5

Vancouver

Cheng S, Chen M, Wu Y, Liu J, Zhong X, Zhang Y, et al. Precision photodamage of RNA and mitochondria for cancer therapy with upconversion nanoparticles. Microchimica Acta. 2025. doi:10.1007/s00604-025-07332-5

BibTeX
@article{Cheng2025,
  author = {Cheng, Shuwen and Chen, Menghang and Wu, Yihan and Liu, Jinliang and Zhong, Xiaoqin and Zhang, Yong and Dou, Qingqing},
  title = {Precision photodamage of RNA and mitochondria for cancer therapy with upconversion nanoparticles},
  journal = {Microchimica Acta},
  year = {2025},
  doi = {10.1007/s00604-025-07332-5}
}
Kostenlos starten →